Understanding diabetes management in patients with end-stage kidney disease
Official title: Pharmaco-epidemiology of diabetes in patients with end-stage kidney disease
Funded at University of Miami School of Medicine · NIH-11042745 · Data updated 2026-11-12
This study looks at how people with diabetes and severe kidney disease are treated, focusing on the risks of low and high blood sugar, to see how different diabetes medications affect their health and hospital visits, especially for those in minority groups who are more affected by these issues.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project start | February 15, 2024 |
| Project end | November 30, 2025 |
| Funding year | 2025 |
| Award (this year) | $115,125 |
| NIH project number | 5R03DK138255-02 |
| Project ID | NIH-11042745 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adults over 21 years old who have diabetes and are undergoing dialysis for end-stage kidney disease.
✕Less likely to help
Patients without diabetes or those not on dialysis for end-stage kidney disease may not benefit from this research.
What this research studies
This research investigates how diabetes is managed in patients with end-stage kidney disease (ESKD), particularly focusing on the risks of severe complications like hypoglycemia and hyperglycemia. By analyzing data from the United States Renal Data System, the study aims to identify current treatment patterns and their effects on health outcomes, including hospitalizations and mortality rates. The research also seeks to understand how different diabetes medications impact these risks, especially among minority populations disproportionately affected by these conditions.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management strategies for patients with end-stage kidney disease, potentially reducing severe complications and hospitalizations.
How similar studies have gone: Previous research has indicated significant challenges in managing diabetes in patients with ESKD, suggesting that this area of study is both relevant and necessary for improving patient outcomes.
Where this research is happening
-
University of Miami School of Medicine
Coral Gables, United States Active
Researchers
- Principal investigator: Galindo, Rodolfo — University of Miami School of Medicine
- Study coordinator: Galindo, Rodolfo
Related research
Other NIH-funded projects on the same topics.
-
How dialysis facility growth affects care for people with end-stage kidney disease
New research will examine whether the spread of dialysis centers and new treatment technologies benefit patients with end-stage kidney disease, and whether benefits reach all communities.
-
Hospital-to-SNF Transitions for Kidney Failure Patients
Aimed at improving how patients with end-stage kidney disease move from hospital to skilled nursing facilities to reduce readmissions.
-
Medically tailored meals for children with kidney failure
A study compares different ways to give tailored meals to kids with end-stage kidney disease to see what works best for families and health.
-
Telehealth for rural patients with end-stage kidney disease
A doctor-researcher at a major university is studying how telehealth can help people with advanced kidney disease in rural areas access care and stay on track for transplantation.
-
Multi-omics study of diabetes, kidney disease, and environment in diverse adults
Researchers are building a diverse group of adults to learn how environment and biology together affect diabetes and kidney disease, with hopes to improve care for people like them.
-
PFAS exposure and kidney disease risk in teens with type 2 diabetes
Aging and kidney health study in youths with type 2 diabetes to see how a common chemical (PFAS) affects kidney risk and how to prevent or treat it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.